GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioRestorative Therapies Inc (NAS:BRTX) » Definitions » E10

BioRestorative Therapies (BioRestorative Therapies) E10 : $-6,694.30 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is BioRestorative Therapies E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BioRestorative Therapies's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.570. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-6,694.30 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 25.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BioRestorative Therapies was 25.70% per year. The lowest was 25.70% per year. And the median was 25.70% per year.

As of today (2024-05-01), BioRestorative Therapies's current stock price is $1.37. BioRestorative Therapies's E10 for the quarter that ended in Dec. 2023 was $-6,694.30. BioRestorative Therapies's Shiller PE Ratio of today is .


BioRestorative Therapies E10 Historical Data

The historical data trend for BioRestorative Therapies's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRestorative Therapies E10 Chart

BioRestorative Therapies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -16,301.30 -13,903.90 -9,859.93 -6,694.30

BioRestorative Therapies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9,859.93 -9,036.94 -8,352.77 -7,622.07 -6,694.30

Competitive Comparison of BioRestorative Therapies's E10

For the Biotechnology subindustry, BioRestorative Therapies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioRestorative Therapies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioRestorative Therapies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioRestorative Therapies's Shiller PE Ratio falls into.



BioRestorative Therapies E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioRestorative Therapies's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.57/129.4194*129.4194
=-0.570

Current CPI (Dec. 2023) = 129.4194.

BioRestorative Therapies Quarterly Data

per share eps CPI Adj_EPS
201403 -6,138.510 99.695 -7,968.767
201406 -4,272.880 100.560 -5,499.168
201409 -2,843.550 100.428 -3,664.429
201412 -3,500.810 99.070 -4,573.272
201503 -3,793.360 99.621 -4,928.016
201506 -2,037.730 100.684 -2,619.305
201509 -2,277.470 100.392 -2,935.994
201512 -3,771.740 99.792 -4,891.518
201603 -2,532.920 100.470 -3,262.742
201606 -2,179.940 101.688 -2,774.430
201609 -1,653.630 101.861 -2,101.018
201612 -1,751.850 101.863 -2,225.774
201703 -2,091.410 102.862 -2,631.375
201706 -2,002.320 103.349 -2,507.415
201709 -1,464.730 104.136 -1,820.362
201712 -1,217.040 104.011 -1,514.344
201803 -1,547.940 105.290 -1,902.692
201806 -2,084.470 106.317 -2,537.425
201809 -1,341.860 106.507 -1,630.533
201812 -1,217.760 105.998 -1,486.839
201903 -1,054.350 107.251 -1,272.286
201906 -840.176 108.070 -1,006.159
201909 -852.922 108.329 -1,018.972
201912 -79.671 108.420 -95.102
202003 -18.940 108.902 -22.508
202006 7.213 108.767 8.583
202009 -2.098 109.815 -2.473
202012 -8.052 109.897 -9.482
202103 -19.715 111.754 -22.831
202106 -4.854 114.631 -5.480
202109 -4.995 115.734 -5.586
202112 -5.796 117.630 -6.377
202203 -1.370 121.301 -1.462
202206 -1.280 125.017 -1.325
202209 -1.280 125.227 -1.323
202212 -1.180 125.222 -1.220
202303 -1.530 127.348 -1.555
202306 -0.770 128.729 -0.774
202309 -0.640 129.860 -0.638
202312 -0.570 129.419 -0.570

Add all the adjusted EPS together and divide 10 will get our e10.


BioRestorative Therapies  (NAS:BRTX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BioRestorative Therapies E10 Related Terms

Thank you for viewing the detailed overview of BioRestorative Therapies's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BioRestorative Therapies (BioRestorative Therapies) Business Description

Traded in Other Exchanges
Address
40 Marcus Drive, Suite One, Melville, NY, USA, 11747
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
Executives
Dale Broadrick 10 percent owner 3003 BRICK CHURCH PIKE, NASHVILLE TN 37207
Lance Alstodt director, 10 percent owner, officer: President, CEO, COB BIORESTORATIVE THERAPIES, INC., 40 MARCUS DRIVE, SUITE 1, MELVILLE NY 11747
Francisco Silva director, 10 percent owner, officer: VP of Research and Development STEM CELL ASSURANCE, INC., 555 HERITAGE DRIVE, JUPITER FL 33458
Robert Eugene Kristal officer: Chief Financial Officer 4719 COLE AVENUE, DALLAS TX 75205
Patrick F. Williams director C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
David A Rosa director 10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343
Nickolay V. Kukekov director 4524 WESTWAY AVE, DALLAS TX 75205
Mark Weinreb director, 10 percent owner, officer: CEO and Chairman of the Board STEM CELL ASSURANCE, INC., 555 HERITAGE DRIVE, JUPITER FL 33458
Paul Jude Tonna director 69 CHICHESTER ROAD, HUNTINGTON NY 11743
A. Jeffrey Radov director 8 WALWORTH AVENUE, SCARSDALE NY 10583
Robert Paccasassi officer: VP, Quality and Compliance C/O BIORESTORATIVE THERAPIES, INC., 40 MARCUS DRIVE, SUITE 1, MELVILLE NY 11747
Robert B Catell director 62 OSBORNE ROAD, GARDEN CITY NY 11530
Adam D. Bergstein officer: SVP, Planning and Business Dev 167 HAZEL AVENUE, GLENCOE IL 60022
John M Desmarais director 230 PARK AVENUE, NEW YORK NY 10169
Westbury Trust 10 percent owner VICTORIA HALL, 11 VICTORIA STREET, P.O. BOX HM 1065, HAMILTON D0 00000

BioRestorative Therapies (BioRestorative Therapies) Headlines

From GuruFocus